spi1 antibody Search Results


antibodies against spi1  (Proteintech)
93
Proteintech antibodies against spi1
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Antibodies Against Spi1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against spi1/product/Proteintech
Average 93 stars, based on 1 article reviews
antibodies against spi1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
spi1 a20461  (ABclonal Biotechnology)
90
ABclonal Biotechnology spi1 a20461
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Spi1 A20461, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spi1 a20461/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
spi1 a20461 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rabbit polyclonal to zebrafish spi1 b antibody  (GeneTex)
90
GeneTex rabbit polyclonal to zebrafish spi1 b antibody
Fig. 1 <t>SPI1</t> expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001
Rabbit Polyclonal To Zebrafish Spi1 B Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal to zebrafish spi1 b antibody/product/GeneTex
Average 90 stars, based on 1 article reviews
rabbit polyclonal to zebrafish spi1 b antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 SPI1 expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 1 SPI1 expression in ccRCC. a, b SPI1 protein and mRNA expression levels were elevated in ccRCC bulk tissues compared to normal bulk tissues in the UALCAN database. c SPI1protein expression levels in six pairs ccRCC tumor bulk tissues and adjacent normal bulk tissues as well as ccRCC cell lines. d SPI1 mRNA expression levels in eight ccRCC tumor bulk tissues and adjacent normal bulk tissues (e) SPI1 protein expression levels was elevated in ccRCC stroma compared to normal stroma in our cohort. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 2 Relationship between SPI1 expression and clinicopathological parameters in ccRCC. a Clinicopathological parameters correlated with SPI1 expression. b–e High SPI1 expression level was associated with high Furman grade (b), T stage (c), positive nodal status (d), and metas- tasis status (e). ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 2 Relationship between SPI1 expression and clinicopathological parameters in ccRCC. a Clinicopathological parameters correlated with SPI1 expression. b–e High SPI1 expression level was associated with high Furman grade (b), T stage (c), positive nodal status (d), and metas- tasis status (e). ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 3 Prognostic value of SPI1. a, b High SPI1 expression level predicted poor OS (a) and PFS b in ccRCC. c, d OS (c) and PFS (d) predictions of patients with ccRCC at five years after surgery are shown in nomograms. e, f Calibration plots of the nomograms for the prediction of five- year OS e and PFS f. ccRCC clear cell renal cell carcinoma; OS overall survival; PFS progression-free survival

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 3 Prognostic value of SPI1. a, b High SPI1 expression level predicted poor OS (a) and PFS b in ccRCC. c, d OS (c) and PFS (d) predictions of patients with ccRCC at five years after surgery are shown in nomograms. e, f Calibration plots of the nomograms for the prediction of five- year OS e and PFS f. ccRCC clear cell renal cell carcinoma; OS overall survival; PFS progression-free survival

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 4 Relationship between SPI1 expression and CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration. a SPI1 expression correlated posi- tively with CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration in our cohort. b SPI1, CD68 + , CD8 + , and CD4 + expression levels in the same patients are shown by IHC. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001; IHC, immunohistochemistry

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 4 Relationship between SPI1 expression and CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration. a SPI1 expression correlated posi- tively with CD68 + macrophages, CD4 + T cells, and CD8 + T cells infiltration in our cohort. b SPI1, CD68 + , CD8 + , and CD4 + expression levels in the same patients are shown by IHC. ccRCC, clear cell renal cell carcinoma; *, p < 0.05; **, p < 0.01; ***, p < 0.001; IHC, immunohistochemistry

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing, Immunohistochemistry

Fig. 5 Relationship between SPI1 expression and immunotherapy efficacy. a SPI1 expression in three responders receiving immunotherapy. b SPI1 expression in four non-responders receiving immunotherapy. Responders included patients with complete disease and partial dis- ease, and non-responders included patients with progressive disease and stable disease

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 5 Relationship between SPI1 expression and immunotherapy efficacy. a SPI1 expression in three responders receiving immunotherapy. b SPI1 expression in four non-responders receiving immunotherapy. Responders included patients with complete disease and partial dis- ease, and non-responders included patients with progressive disease and stable disease

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: Expressing

Fig. 6 Genes coexpressed with SPI1 in KIRC using the LinkedOmics database. a, b The top 50 genes positively and negatively associated with SPI1 shown in the heat maps. Blue represents negatively linked genes and red represents positively linked genes. c, d Gene Ontology annotations c and Kyoto Encyclopedia of Genes and Genomes pathways (d) of SPI1 in KIRC cohort. KIRC, kidney renal clear cell carcinoma

Journal: Discover. Oncology

Article Title: SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.

doi: 10.1007/s12672-022-00592-0

Figure Lengend Snippet: Fig. 6 Genes coexpressed with SPI1 in KIRC using the LinkedOmics database. a, b The top 50 genes positively and negatively associated with SPI1 shown in the heat maps. Blue represents negatively linked genes and red represents positively linked genes. c, d Gene Ontology annotations c and Kyoto Encyclopedia of Genes and Genomes pathways (d) of SPI1 in KIRC cohort. KIRC, kidney renal clear cell carcinoma

Article Snippet: Antibodies against SPI1 (66618–2-lg; Proteintech) andβ-Tubulin (BE0025; EASYBIO) were used.

Techniques: